Literature DB >> 16760271

Gastric adenomas: relationship between clinicopathological findings, Helicobacter pylori infection, APC mutations and COX-2 expression.

A Rocco1, R Caruso, S Toracchio, L Rigoli, F Verginelli, T Catalano, M Neri, M C Curia, L Ottini, V Agnese, V Bazan, A Russo, G Pantuso, G Colucci, R Mariani-Costantini, G Nardone.   

Abstract

Gastric adenomas are rare neoplastic growths characterized by localized polypoid proliferations of dysplastic epithelium that tend to progress to infiltrating adenocarcinoma. Therefore, the identification of molecular markers that could reliably recognize adenomas at risk of progression is advocated in the clinical management. In this study we investigated, in a series of gastric adenoma specimens from an area at high risk of gastric cancer, the relationship between clinicopathological characteristics of adenoma and Helicobacter pylori infection, APC mutational status, and COX-2 and the down-stream enzyme mPGES1 expression. Helicobacter pylori infection, detected in 24%, and 33% by histology and PCR analyses, respectively, did not show any relationship with growth pattern, localization, size, dysplasia grade and presence of synchronous cancer. Pathogenetic mutations of MCR region (codons 1269-1589) of the APC gene were detected only in one case corresponding to a single, small size, low grade, H. pylori-negative adenoma. The expression of COX-2 largely matched that of mPGES(1). Both were overexpressed in 79% of cases showing a relationship with high-grade dysplasia, size >10 mm and presence of a synchronous carcinoma. In conclusion, COX-2 may play a key role in the development and progression of gastric adenoma and could be an attractive target in the management of gastric adenoma at major risk of cancer development.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16760271     DOI: 10.1093/annonc/mdl961

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  9 in total

1.  Features of Gastric Neoplasm Detected during the Screening Examination.

Authors:  Min Jung Park; Dong Hee Kim; Seon Hee Lim; Jeong Yoon Yim; Young Sun Kim; Kyung Ran Cho; Chung Hyeon Kim; Hyun Chae Jung; In Sung Song; Sun Sin Kim; Dae Hyun Yoon; Chan Soo Shin; Sang-Heon Cho; Byung-Hee Oh; Dong Ho Lee
Journal:  Gut Liver       Date:  2007-06-30       Impact factor: 4.519

2.  Association of current Helicobacter pylori infection and metabolic factors with gastric cancer in 35,519 subjects: A cross-sectional study.

Authors:  Su Youn Nam; Bum Joon Park; Ji Hyung Nam; Kum Hei Ryu; Myeong-Cherl Kook; Jeongseon Kim; Won Kee Lee
Journal:  United European Gastroenterol J       Date:  2018-12-12       Impact factor: 4.623

Review 3.  Identification and development of mPGES-1 inhibitors: where we are at?

Authors:  Hui-Hua Chang; Emmanuelle J Meuillet
Journal:  Future Med Chem       Date:  2011-11       Impact factor: 3.808

4.  Relationship between H.Pylori infection and clinicopathological features and prognosis of gastric cancer.

Authors:  Hai-Bo Qiu; Li-Yi Zhang; Rajiv-Prasad Keshari; Guo-Qiang Wang; Zhi-Wei Zhou; Da-Zhi Xu; Wei Wang; You-Qin Zhan; Wei Li
Journal:  BMC Cancer       Date:  2010-07-17       Impact factor: 4.430

5.  STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice.

Authors:  Matthias Ernst; Meri Najdovska; Dianne Grail; Therese Lundgren-May; Michael Buchert; Hazel Tye; Vance B Matthews; Jane Armes; Prithi S Bhathal; Norman R Hughes; Eric G Marcusson; James G Karras; Songqing Na; Jonathon D Sedgwick; Paul J Hertzog; Brendan J Jenkins
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

6.  Anti-Helicobacter pylori therapy followed by celecoxib on progression of gastric precancerous lesions.

Authors:  Li-Jing Zhang; Shi-Yan Wang; Xiao-Hui Huo; Zhen-Long Zhu; Jian-Kun Chu; Jin-Cheng Ma; Dong-Sheng Cui; Ping Gu; Zeng-Ren Zhao; Ming-Wei Wang; Jun Yu
Journal:  World J Gastroenterol       Date:  2009-06-14       Impact factor: 5.742

7.  Combination of Paris and Vienna classifications may optimize follow-up of gastric epithelial neoplasia patients.

Authors:  Wen Hu; Xin-Bo Ai; Yi-Miao Zhu; Tie-Mei Han; Bo Shen; Wen-Sheng Pan
Journal:  Med Sci Monit       Date:  2015-04-05

8.  Lactoferrin Adsorbed onto Biomimetic Hydroxyapatite Nanocrystals Controlling - In Vivo - the Helicobacter pylori Infection.

Authors:  Andrea Fulgione; Nunzia Nocerino; Marco Iannaccone; Sante Roperto; Federico Capuano; Norberto Roveri; Marco Lelli; Antonio Crasto; Armando Calogero; Argenia Paola Pilloni; Rosanna Capparelli
Journal:  PLoS One       Date:  2016-07-06       Impact factor: 3.240

9.  Hypermethylation of multiple Wnt antagonist genes in gastric neoplasia: Is H pylori infection blasting fuse?

Authors:  Zhenkai Wang; Yaqing Ye; Dan Liu; Xiaoqian Yang; Fangyu Wang
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.